Norethisterone acetate and ethinylestradiol in early human pregnancy.
In a double-blind randomized trial, 25 women (8-9 weeks pregnant) received 20 mg norethisterone acetate (NET-AC) and 0.04 mg ethinylestradiol (EE2), 25 women receiving placebo. The patients were followed by ultrasound and the products at curettage studied macroscopically and microscopically. In an open trial, ten patients (5-9 weeks pregnant) received NET-AC + EE2, 11 serving as controls. The concentrations of plasma progesterone, estradiol-17 beta, 17 alpha-hydroxyprogesterone, norethisterone, and FSH were followed. The frequency of intrauterine hemorrhage in early pregnancy was not affected by NET-AC + EE2. Ultrasound was not reliable when studying the occurrence of decidual hemorrhages during early pregnancy. The pharmacokinetics and bioavailability of NET remain unchanged during early pregnancy. The treatment with NET-AC + EE2 had no effect on the heights and the time courses of the mean plasma values of progesterone, estradiol-17 beta, 17 alpha-hydroxyprogesterone, and FSH. No differences were found between treated and nontreated patients in the pathology of the placenta or decidua as determined by both macroscopic and microscopic examinations. The hypothesis of Papp and Gardo, that decidual hemorrhages may be induced in early pregnancy as a consequence of a "withdrawal effect" of hormonal pregnancy tests, is not supported by the results of this investigation.
D019326:17-alpha-Hydroxyprogesterone; D004311:Double-Blind Method; D004958:Estradiol / Q000097:blood; D004997:Ethinyl Estradiol / Q000009:adverse effects*; D005260:Female; D005640:Follicle Stimulating Hormone / Q000097:blood; D006801:Humans; D006908:Hydroxyprogesterones / Q000097:blood; D007700:Kinetics; D009640:Norethindrone / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000097:blood / Q000378:metabolism; D000077563:Norethindrone Acetate; D011247:Pregnancy; D011258:Pregnancy Tests; D011374:Progesterone / Q000097:blood; D011897:Random Allocation; D014463:Ultrasonography; D014592:Uterine Hemorrhage / Q000139:chemically induced* / Q000175:diagnosis
D006908:Hydroxyprogesterones; D004997:Ethinyl Estradiol; D011374:Progesterone; D004958:Estradiol; D019326:17-alpha-Hydroxyprogesterone; D005640:Follicle Stimulating Hormone; D000077563:Norethindrone Acetate; D009640:Norethindrone